FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $16,912 | +164.6% | 7,212 | 0.0% | 0.00% | – |
Q4 2023 | $6,392 | +2.7% | 7,212 | 0.0% | 0.00% | – |
Q3 2023 | $6,224 | -97.1% | 7,212 | -91.0% | 0.00% | – |
Q2 2023 | $215,787 | -86.1% | 79,921 | -3.9% | 0.00% | -100.0% |
Q1 2023 | $1,551,095 | +24.3% | 83,124 | +6.7% | 0.00% | – |
Q4 2022 | $1,248,022 | +27.3% | 77,904 | +3.4% | 0.00% | – |
Q3 2022 | $980,000 | +25.5% | 75,331 | +1.9% | 0.00% | – |
Q2 2022 | $781,000 | -14.1% | 73,897 | -2.3% | 0.00% | – |
Q1 2022 | $909,000 | -13.8% | 75,611 | +1.0% | 0.00% | – |
Q4 2021 | $1,055,000 | +38.6% | 74,838 | +0.4% | 0.00% | – |
Q3 2021 | $761,000 | -51.1% | 74,505 | +27.5% | 0.00% | -100.0% |
Q2 2021 | $1,556,000 | -20.2% | 58,440 | +4.0% | 0.00% | 0.0% |
Q1 2021 | $1,951,000 | -5.6% | 56,204 | +0.9% | 0.00% | 0.0% |
Q4 2020 | $2,066,000 | +5.3% | 55,708 | +16.8% | 0.00% | 0.0% |
Q3 2020 | $1,962,000 | -5.4% | 47,709 | -6.8% | 0.00% | 0.0% |
Q2 2020 | $2,075,000 | +28.4% | 51,186 | +10.1% | 0.00% | 0.0% |
Q1 2020 | $1,616,000 | -23.9% | 46,506 | -6.0% | 0.00% | 0.0% |
Q4 2019 | $2,123,000 | +36.5% | 49,488 | +17.7% | 0.00% | 0.0% |
Q3 2019 | $1,555,000 | -8.8% | 42,049 | +11.4% | 0.00% | 0.0% |
Q2 2019 | $1,705,000 | -22.9% | 37,749 | -7.2% | 0.00% | 0.0% |
Q1 2019 | $2,212,000 | +53.9% | 40,691 | +31.1% | 0.00% | 0.0% |
Q4 2018 | $1,437,000 | -11.4% | 31,049 | +16.3% | 0.00% | 0.0% |
Q3 2018 | $1,622,000 | -2.9% | 26,698 | -0.0% | 0.00% | 0.0% |
Q2 2018 | $1,671,000 | +31.2% | 26,699 | -3.2% | 0.00% | 0.0% |
Q1 2018 | $1,274,000 | -10.0% | 27,570 | -7.2% | 0.00% | 0.0% |
Q4 2017 | $1,415,000 | -5.7% | 29,724 | +6.3% | 0.00% | 0.0% |
Q3 2017 | $1,500,000 | +119.3% | 27,967 | +31.1% | 0.00% | 0.0% |
Q2 2017 | $684,000 | +45.8% | 21,333 | +12.2% | 0.00% | – |
Q1 2017 | $469,000 | +13.3% | 19,016 | -1.1% | 0.00% | – |
Q4 2016 | $414,000 | +48.9% | 19,237 | +42.3% | 0.00% | – |
Q3 2016 | $278,000 | +53.6% | 13,519 | +22.3% | 0.00% | – |
Q2 2016 | $181,000 | -23.0% | 11,057 | 0.0% | 0.00% | – |
Q1 2016 | $235,000 | -32.9% | 11,057 | -3.0% | 0.00% | – |
Q4 2015 | $350,000 | +66.7% | 11,398 | +19.7% | 0.00% | – |
Q3 2015 | $210,000 | +14.8% | 9,525 | +22.2% | 0.00% | – |
Q2 2015 | $183,000 | +289.4% | 7,793 | +424.8% | 0.00% | – |
Q1 2015 | $47,000 | – | 1,485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 1,735,677 | $93,379,000 | 12.44% |
Omega Fund Management, LLC | 314,348 | $16,912,000 | 9.57% |
Opaleye Management Inc. | 360,000 | $19,368,000 | 6.85% |
NEXTHERA CAPITAL LP | 217,329 | $11,692,000 | 3.01% |
Monashee Investment Management LLC | 122,300 | $6,580,000 | 2.49% |
Hillhouse Capital Management | 2,486,196 | $133,757,000 | 2.21% |
DOHENY ASSET MANAGEMENT /CA | 50,925 | $2,740,000 | 1.26% |
Sicart Associates LLC | 31,072 | $1,672,000 | 1.20% |
Iguana Healthcare Management, LLC | 80,000 | $4,304,000 | 1.19% |
Rhenman & Partners Asset Management AB | 145,500 | $7,828,000 | 1.00% |